$MRVI News
Last published 1w ago
- 1w agoMRVIMaravai LifeSciences Q3 2026 Results Earnings Call - MARAVAI LIFESCIENCES HOLDINGS INCEarnings Call TranscriptsHello and welcome everyone, joining today's Maravai Life Sciences Q3 2026 Results Earnings Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the
- 1w agoMRVIMaravai LifeSciences Announces November 2026 Investor Conference ScheduleBusiness WireMaravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month
- 4w agoMRVIMaravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026Business WireMaravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter financial and operating results
- 1mo agoMRVITriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IPBusiness WireNew Patent Protects the CleanCap® Cap Analog Compounds Themselves and mRNA-Based Pharmaceutical Compositions — Extending Beyond Method Claims to Cover the Molecules at the Heart of Modern mRNA Medicines TriLink
- 3mo agoMRVIMaravai LifeSciences Reports Second Quarter 2026 Financial ResultsBusiness WireSecond quarter 2026 total revenue up 9% from prior year Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators,
- 3mo agoMRVIMaravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026Business WireMaravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter financial and operating results
- 3mo agoMRVITriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping TechnologyBusiness WireTriLink's Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs TriLink BioTechnologies, LLC (TriLink®), a
- 4mo agoMRVITriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial ScaleBusiness WireNew Jupiter, FL facility enables RNA therapeutics developers to source critical manufacturing materials from a single, coordinated supplier, simplifying workflows and accelerating development timelines. TriLink, part
- 5mo agoMRVIMaravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032Business WireMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that certain of its subsidiaries have entered into a new
- 5mo agoMRVIMaravai LifeSciences To Attend The Jefferies Global Healthcare ConferenceBusiness WireMaravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company will participate in the following investor
- 6mo agoMRVIMaravai LifeSciences Q1 2026 Results Earnings CallMARAVAI LIFESCIENCES HOLDINGS INCEarnings Call TranscriptsHello and welcome everyone joining today's Miravai Life Sciences Q1 2026 Earnings Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question
- 6mo agoMRVIMaravai LifeSciences Reports First Quarter 2026 Financial ResultsBusiness WireFirst quarter 2026 total revenue up 41% from prior year Base revenue excluding revenue for high-volume CleanCap for commercialized COVID-19 vaccines up 10% from prior year Maravai LifeSciences Holdings, Inc.
- 6mo agoMRVIMaravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026Business WireMaravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2026 financial and operating results
- 8mo agoMRVIMaravai LifeSciences Q4 2025 Results Earnings CallMARAVAI LIFESCIENCES HOLDINGS INCEarnings Call TranscriptsHello and welcome everyone joining today's Maravai Life Sciences Q4 2025 results earnings call. At this time all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the qu
- 8mo agoMRVIMaravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial ResultsBusiness WireOrganizational restructuring and operating cost reduction ahead of plan Focus on operational excellence, revenue growth, and improving Adjusted EBITDA Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a
- 9mo agoMRVIMaravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026Business WireMaravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2025 financial and
- 1y agoMRVIMaravai LifeSciences Announces November 2025 Investor Conference ScheduleBusiness WireMaravai LifeSciences, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month
- 1y agoMRVIMaravai LifeSciences Reports Third Quarter 2025 Financial ResultsBusiness WireOrganizational restructuring and operating cost reduction initiatives on track Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and
- 1y agoMRVIMaravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025Business WireMaravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2025 financial and operating results
- 1y agoMRVIMaravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoMRVIMaravai LifeSciences Reports Second Quarter 2025 Financial ResultsGlobeNewswireAnnounced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings Quarterly base business revenue, which excludes revenue from high-volume
- 1y agoMRVIMaravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025GlobeNewswireSAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its
- 1y agoMRVIMaravai LifeSciences Appoints Rajesh Asarpota as Chief Financial OfficerGlobeNewswireSAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh
- 1y agoMRVIMaravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of DirectorsGlobeNewswireSAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the
- 1y agoMRVITriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping TechnologyBusiness WireQuantoom's customers can now access TriLink's CleanCap mRNA capping technology; Agreement supports future expansion of essential therapeutics & vaccines in developing countries & regions TriLink
- 1y agoMRVICORRECTION – Maravai LifeSciences Releases 2024 Sustainability ReportGlobeNewswireAccelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy
- 1y agoMRVIMaravai LifeSciencesReleases 2024 Sustainability ReportGlobeNewswireAccelerates product innovation, expands GMP manufacturing capacity, and deepens corporate-wide commitment to responsible growth Debuts enhanced greenhouse gas accounting across Scopes 1-3 and advances renewable energy
- 1y agoMRVITriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutionsBusiness WireNew all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with efficient capping, increased yield, reduced dsRNA, and
- 1y agoMRVITriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based VaccinesBusiness WireToday, TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ:MRVI) and global provider of life science reagents and services, and the International Vaccine Institute (IVI), a non-profit
- 1y agoMRVIMaravai Lifesciences Reports First Quarter 2025 Financial ResultsGlobeNewswireSAN DIEGO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today
- 1y agoMRVIMaravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025GlobeNewswireSAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first
- 1y agoMRVIMRVI Investors Have the Opportunity to Lead the Maravai LifeSciences Securities Fraud Lawsuit with Faruqi & Faruqi, LLPGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options If you
- 1y agoMRVIMaravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights - MRVIPR NewswireThe Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased...
- 1y agoMRVIMaravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights – MRVIGlobeNewswireNEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI). Shareholders who purchased shares of MRVI during the
- 1y agoMRVIThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Holdings, Inc. Lawsuit – MRVIGlobeNewswireNEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI). Shareholders who purchased shares of MRVI during the
- 1y agoMRVIMRVI Investors Have the Opportunity to Lead the Maravai LifeSciences Securities Fraud Lawsuit with Faruqi & Faruqi, LLPGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options If you
- 1y agoMRVISHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc....
- 1y agoMRVIINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options If you
- 1y agoMRVIMaravai LifeSciences Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights - MRVIPR NewswireThe Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased...
- 1y agoMRVIMaravai LifeSciences Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights – MRVIGlobeNewswireNEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI). Shareholders who purchased shares of MRVI during the
- 1y agoMRVIINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc....
- 1y agoMRVIMaravai LifeSciences Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before May 5, 2025 to Discuss Your Rights – MRVIGlobeNewswireNEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI). Shareholders who purchased shares of MRVI during the
- 1y agoMRVIMaravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewswireSAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported
- 1y agoMRVIINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Maravai LifeSciences To Contact Him Directly To Discuss Their Options If purchased or acquired
- 1y agoMRVISHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc....
- 1y agoMRVISHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options If you
- 1y agoMRVIMRVI LAWSUIT: Maravai LifeSciences Holdings Inc. Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover LossesGlobeNewswireBOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Block & Leviton announces that a securities fraud lawsuit has been filed against Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) and certain of its executives. Investors
- 1y agoMRVIKirby McInerney LLP Announces Investigation Against Maravai Lifesciences Holdings, Inc. (MRVI) on Behalf of InvestorsGlobeNewswireNEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Maravai Lifesciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ:MRVI). The
- 1y agoMRVIMRVI DOWN 24%: Maravai Lifesciences Under Investigation for Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover LossesGlobeNewswireBOSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Maravai Lifesciences Holdings, Inc (NASDAQ:MRVI) for potential securities law violations. Investors who have lost money in their Maravai
- 1y agoMRVIMaravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference CallGlobeNewswireSAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ:MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced